Investor
Aescap
- AI
- Biotech
- Headquarters:
- Amsterdam
Description
Aescap manages liquid biotech investment funds that concentrate on companies applying AI to life‑science R&D, aiming to accelerate development and reduce costs for therapeutics and diagnostics.
Related
Ångström AIÅngström AI develops diagnostics using amplicon sequencing and machine learning, aiming to broaden access to sequencing-based diagnostic…
Domain AssociatesDomain Associates advises and manages biotech venture funds, providing VC funding to biopharmaceutical, medical device, and diagnostic…
Kleiner PerkinsKleiner Perkins invests in and helps build technology and life sciences companies, supporting recruiting, business development, and sectors…
Oslo Cancer ClusterOslo Cancer Cluster builds collaborations and services that accelerate development of new cancer diagnostics and treatments for healthcare…
IndieBioIndieBio provides onsite biolabs and pre-seed investment for scientists launching startups across biotech, food, agriculture, industrial…
ARCH Venture PartnersARCH Venture Partners invests in early-stage science and technology companies, helping scientists and entrepreneurs develop discoveries…
Thiel CapitalPeter Thiel's personal investment vehicle. Backs frontier tech founders alongside Founders Fund.
Enveda BiosciencesEnveda Biosciences uses biological data and machine learning to identify natural-product-derived compounds and accelerate small-molecule…
InterlagosInterlagos is a technology investment company focused on applied science and manufacturing, providing capital and support to technology…
Quantum BiometronicsQuantum Biometronics builds precision quantum-enabled instruments and sensors for life sciences and biotech customers, including…
manas aimanas ai builds AI solutions and advises teams on trends, strategy, and adoption planning to automate processes, reduce costs, and improve…
Safar PartnersSafar Partners invests in university-originated technology startups, supporting portfolio companies in cleantech, advanced materials, AI,…